Comprehensive packages including regular consultations, nutritional counselling, exercise guidance, and psychological support cost more but may improve outcomes
Many add permeation enhancers, adjust pH levels, and use specific concentrations designed to optimize sublingual absorption
Current clinical consensus reflects the following: Research findings are preliminary and insufficient to guide treatment decisions No regulatory approval exists for using GLP-1s in addiction treatment Early signals do not outweigh the lack of long-term outcome data Instead, clinicians continue to recommend established, evidence-based approaches, including: Behavioral therapies tailored to substance use disorders Medication-assisted treatment when medically indicated Comprehensive psychosocial support and relapse-prevention planning Comprehensive assessment remains a cornerstone of safe and effective care
In some cases, results from large human trials are already in
For a full list of side effects, please review the Mayo Clinics Semaglutide and Tirzepatide resources